Authors
-
Yan Yan
Clinical Medical Research Center, The Fifth People's Hospital of Wuxi, Wuxi Academy of Nantong University, Wuxi 214016, China.
Author
-
Chantsalmaa Davgadorj
Clinical Medical Research Center, The Fifth People's Hospital of Wuxi, Wuxi Academy of Nantong University, Wuxi 214016, China
Author
-
Xu Wang
Clinical Medical Research Center, The Fifth People's Hospital of Wuxi, Wuxi Academy of Nantong University, Wuxi 214016, China
Author
-
Yonghua Zhou
Key Laboratory of National Health and Family Planning Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
Author
Keywords:
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Vaccine, Coronavirus Disease 2019 (COVID-19), Toxoplasma Gondii, Tuberculosis
Abstract
Using a case-control study, we compared the antibody-positive profiles for Toxoplasma gondii in patients infected with SARS-CoV-2, tuberculosis (TB), HBV, and HIV-1 in Wuxi of China. As an important pathogen, Toxoplasma gondii has higher co-infection and reactivation rates in patients with SARSCoV-2 and TB infection.
Author Biographies
-
Yan Yan, Clinical Medical Research Center, The Fifth People's Hospital of Wuxi, Wuxi Academy of Nantong University, Wuxi 214016, China.
Yan Yan, Clinical Medical Research Center, The Fifth People's Hospital of Wuxi, Wuxi Academy of Nantong University, Wuxi 214016, China.
-
Chantsalmaa Davgadorj, Clinical Medical Research Center, The Fifth People's Hospital of Wuxi, Wuxi Academy of Nantong University, Wuxi 214016, China
Chantsalmaa Davgadorj, Clinical Medical Research Center, The Fifth People's Hospital of Wuxi, Wuxi Academy of Nantong University, Wuxi 214016, China
-
Xu Wang, Clinical Medical Research Center, The Fifth People's Hospital of Wuxi, Wuxi Academy of Nantong University, Wuxi 214016, China
Xu Wang, Clinical Medical Research Center, The Fifth People's Hospital of Wuxi, Wuxi Academy of Nantong University, Wuxi 214016, China
-
Yonghua Zhou, Key Laboratory of National Health and Family Planning Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
Yonghua Zhou, Key Laboratory of National Health and Family Planning Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
